RMD 0.54% $37.28 resmed inc

{"streaming_server":"rtmp:\/\/s2svek4dh1hfyu.cloudfront.net\/cfx\...

  1. lightbulb Created with Sketch. 1
    .


    ResMed Inc. (ASX:RMD, NYSE:RMD) has posted a strong start to the new financial year, boosting first quarter earnings by more than expected. 




    The manufacturer and distributor of medical equipment posted a record quarterly net profit of $US71.3 million at the end of last week, about $US20 million up from last year and $US8 million more than expected by analysts. 




    In the same period quarterly revenues increased 8 per cent to $US340 million, up from $US315 million the year before.




    Dual-listed Res-Med has operations in more than 70 countries and its September quarter result was aided by 15 per cent growth from US markets. 




    Shares in California-based Resmed rose to record highs after the announcement but pulled back to finish last week at $3.99 on the Australian Securities Exchange (ASX). 




    ResMed’s annual net profit grew 12 per cent to $250 million in the 2012 financial year. 

 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.28
Change
0.200(0.54%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.50 $37.55 $37.15 $17.93M 480.5K

Buyers (Bids)

No. Vol. Price($)
1 3363 $37.27
 

Sellers (Offers)

Price($) Vol. No.
$37.30 1001 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.